Avinger (NASDAQ:AVGR – Get Free Report) and Spectral AI (NASDAQ:MDAI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.
Risk & Volatility
Avinger has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings for Avinger and Spectral AI, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avinger | 0 | 0 | 1 | 0 | 3.00 |
| Spectral AI | 0 | 0 | 3 | 1 | 3.25 |
Profitability
This table compares Avinger and Spectral AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avinger | -261.06% | -5,527.11% | -123.25% |
| Spectral AI | -40.78% | N/A | -77.87% |
Earnings & Valuation
This table compares Avinger and Spectral AI”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avinger | $7.65 million | 0.35 | -$18.32 million | ($11.06) | -0.07 |
| Spectral AI | $18.06 million | 1.22 | -$20.85 million | ($0.65) | -1.83 |
Avinger has higher earnings, but lower revenue than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
18.3% of Avinger shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 43.7% of Avinger shares are held by company insiders. Comparatively, 56.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Spectral AI beats Avinger on 11 of the 15 factors compared between the two stocks.
About Avinger
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
About Spectral AI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
